PEGylated human plasma fibronectin is proteolytically stable, supports cell adhesion, cell migration, focal adhesion assembly, and fibronectin fibrillogenesis

Biotechnology Progress

Volumn 29, Issue 2, 2013, Pages 493-504

  Zhang, Chen ^a   Hekmatfar, Sogol ^a   Ramanathan, Anand ^a   Karuri, Nancy W ^a  

^a Illinois Institute of Technology   (United States)

Author keywords

Adhesion; Chymotrypsin; Fibrillogenesis; Fibronectin; Focal adhesion; Migration; Neutrophil elastase; Polyethylene glycol; Proteolysis; Spreading

Indexed keywords

CHYMOTRYPSIN; ELASTASE; FIBRILLOGENESIS; FIBRONECTIN; FOCAL ADHESIONS; MIGRATION; SPREADING;

ADHESION; CELL ADHESION; CELL CULTURE; FIBROBLASTS; FLUORESCENCE MICROSCOPY; PLASMA (HUMAN); POLYETHYLENE GLYCOLS; PROTEOLYSIS; TISSUE REGENERATION;

BIOMATERIALS;

CHYMOTRYPSIN; FIBRONECTIN; MACROGOL DERIVATIVE; PANCREATIC ELASTASE;

ANIMAL; ARTICLE; CELL ADHESION; CELL MOTION; CELL STRAIN 3T3; CHEMISTRY; CYTOLOGY; EXTRACELLULAR MATRIX; FIBROBLAST; FOCAL ADHESION; HUMAN; METABOLISM; MOLECULAR WEIGHT; MOUSE; PROTEIN DEGRADATION; PROTEIN STABILITY; WOUND HEALING;

3T3 CELLS; ANIMALS; CELL ADHESION; CELL MOVEMENT; CHYMOTRYPSIN; EXTRACELLULAR MATRIX; FIBROBLASTS; FIBRONECTINS; FOCAL ADHESIONS; HUMANS; MICE; MOLECULAR WEIGHT; PANCREATIC ELASTASE; POLYETHYLENE GLYCOLS; PROTEIN STABILITY; PROTEOLYSIS; WOUND HEALING;

EID: 84875948110     PISSN: 87567938     EISSN: 15206033     Source Type: Journal    
DOI: 10.1002/btpr.1689     Document Type: Article

References (63)

1. Nwomeh BC, Yager DR, Cohen IK. Physiology of the chronic wound. Clin Plast Surg. 1998;25:341-356.
2. Grinnell F, Zhu M. Identification of neutrophil elastase as the proteinase in burn wound fluid responsible for degradation of fibronectin. J Invest Dermatol. 1994;103 155-161.
3. Rao CN, Ladin DA, Liu YY, Chilukuri K, Hou ZZ, Woodley DT. Alpha 1-antitrypsin is degraded and non-functional in chronic wounds but intact and functional in acute wounds: the inhibitor protects fibronectin from degradation by chronic wound fluid enzymes. J Invest Dermatol. 1995;105:572-578.
4. Trengove NJ, Stacey MC, MacAuley S, Bennett N, Gibson J, Burslem F, Murphy G, Schultz G. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen. 1999;7:442-452.
5. Ugarova TP, Ljubimov AV, Deng L, Plow EF. Proteolysis regulates exposure of the IIICS-1 adhesive sequence in plasma fibronectin. Biochemistry. 1996;35:10913-10921.
6. Menke NB, Ward KR, Witten TM, Bonchev DG, Diegelmann RF. Impaired wound healing. Clin Dermatol. 2007;25:19-25.
7. Moor AN, Vachon DJ, Gould LJ. Proteolytic activity in wound fluids and tissues derived from chronic venous leg ulcers. Wound Repair Regen. 2009;17:832-839.
8. Wilgus TA. Immune cells in the healing skin wound: influential players at each stage of repair. Pharmacol Res. 2008;58:112-116.
9. Wysocki AB, Grinnell F. Fibronectin profiles in normal and chronic wound fluid. Lab Invest. 1990;63:825-831.
10. Clark RA. Potential roles of fibronectin in cutaneous wound repair. Arch Dermatol. 1988;124:201-206.
11. Singh P, Carraher C, Schwarzbauer JE. Assembly of Fibronectin Extracellular Matrix. Annu Rev Cell Dev Biol. 2010;26:397-419.
12. Kapila YL, Kapila S, Johnson PW. Fibronectin and fibronectin fragments modulate the expression of proteinases and proteinase inhibitors in human periodontal ligament cells. Matrix Biol. 1996;15:251-261.
13. Norris DA, Clark RA, Swigart LM, Huff JC, Weston WL, Howell SE. Fibronectin fragment(s) are chemotactic for human peripheral blood monocytes. J Immunol. 1982;129:1612-1618.
14. Shiota S, Takano K, Nakagawa H. A 10-kda fragment of fibronectin type III domain is a neutrophil chemoattractant purified from conditioned medium of rat granulation tissue. Biol Pharm Bull. 2001;24:835-837.
15. Grinnell F. Fibronectin and wound healing. J Cell Biochem. 1984;26:107-116.
16. McDonald JA, Quade BJ, Broekelmann TJ, LaChance R, Forsman K, Hasegawa E, Akiyama S. Fibronectin's cell-adhesive domain and an amino-terminal matrix assembly domain participate in its assembly into fibroblast pericellular matrix. J Biol Chem. 1987;262:2957-2967.
17. Sechler JL, Rao H, Cumiskey AM, Vega-Colon I, Smith MS, Murata T, Schwarzbauer J E. A novel fibronectin binding site required for fibronectin fibril growth during matrix assembly. J Cell Biol. 2001;154:1081-1088.
18. Grinnell F, Feld M, Minter D. Fibroblast adhesion to fibrinogen and fibrin substrata: requirement for cold-insoluble globulin (plasma fibronectin). Cell. 1980;19:517-525.
19. Yang C, Lu D, Liu Z. How PEGylation enhances the stability and potency of insulin: a molecular dynamics simulation. Biochemistry. 2011;50:2585-2593.
20. Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals. Int J Pharm. 1999;185:129-188.
21. Veronese FM, Mero A. The impact of PEGylation on biological therapies. BioDrugs. 2008;22:315-329.
22. Allen-Hoffmann BL, Crankshaw CL, Mosher DF. Transforming growth factor beta increases cell surface binding and assembly of exogenous (plasma) fibronectin by normal human fibroblasts. Mol Cell Biol. 1988;8:4234-4242.
23. Powanda MC, Moyer ED. Plasma proteins and wound healing. Surg Gynecol ObstetI. 1981;153:749-755.
24. To WS, Midwood KS. Plasma and cellular fibronectin: distinct and independent functions during tissue repair. Fibrogenesis Tissue Repair. 2011;4:21-38.
25. Balian G, Click EM, Crouch E, Davidson JM, Bornstein P. Isolation of a collagen-binding fragment from fibronectin and cold-insoluble globulin. J Biol Chem. 1979;254:1429-1432.
26. Lemmon CA, Ohashi T, Erickson HP. Probing the folded state of fibronectin type III domains in stretched fibrils by measuring buried cysteine accessibility. J Biol Chem. 2011;286:26375-26382.
27. Aguirre KM, McCormick RJ, Schwarzbauer JE. Fibronectin self-association is mediated by complementary sites within the amino-terminal one-third of the molecule. J Biol Chem. 1994; 269:27863-27868.
28. Hocking DC, Sottile J, McKeown-Longo PJ. Fibronectin's III-1 module contains a conformation-dependent binding site for the amino-terminal region of fibronectin. J Biol Chem. 1994; 269:19183-19187.
29. Maqueda A, Moyano JV, Hernandez Del Cerro M, Peters DM, Garcia-Pardo A. The heparin III-binding domain of fibronectin (III4-5 repeats) binds to fibronectin and inhibits fibronectin matrix assembly. Matrix Biol. 2007;26:642-651.
30. Hocking DC, Smith RK, McKeown-Longo PJ. A novel role for the integrin-binding III-10 module in fibronectin matrix assembly. J Cell Biol. 1996;133:431-444.
31. Bultmann H, Santas AJ, Peters DMP. Fibronectin fibrillogenesis involves the heparin II binding domain of fibronectin. J Biol Chem. 1998;273:2601-2609.
32. Millis AJT, Hoyle M, Mann DM, Brennan MJ. Incoporation of cellular and plasma fibronectin into smooth-muscle cell exreacellular-matrix invitro. Proc Natl Acad Sci USA. 1985; 82:2746-2750.
33. Martino MM. Hubbell JA. The 12th-14th type III repeats of fibronectin function as a highly promiscuous growth factor-binding domain. FASEB J. 2010;24:4711-4721.
34. Elbert DL, Hubbell JA. Conjugate addition reactions combined with free-radical cross-linking for the design of materials for tissue engineering. Biomacromolecules. 2001;2:430-441.
35. Cruise GM, Scharp DS, Hubbell JA. Characterization of permeability and network structure of interfacially photopolymerized poly(ethylene glycol) diacrylate hydrogels. Biomaterials. 1998;19:1287-1294.
36. Lutolf MP, Tirelli N, Cerritelli S, Cavalli L, Hubbell JA. Systematic modulation of Michael-type reactivity of thiols through the use of charged amino acids. Bioconjug Chem. 2001; 12:1051-1056.
37. Salinas CN, Anseth KS. Mixed mode thiol-acrylate photopolymerizations for the synthesis of PEG-peptide hydrogels. Macromolecules. 2008;41:6019-6026.
38. Pankov R, Yamada KM. Fibronectin at a glance. J Cell Sci. 2002;115:3861-3863.
39. Kshatriya PP, Karuri SW, Chiang C, Karuri, NW. A combinatorial approach for directing the amount of fibronectin fibrils assembled by cells that uses surfaces derivatized with mixtures of fibronectin and cell binding domains. Biotechnol Progr. 2012; 28: 862-871.
40. Chiang C, Karuri, SW, Kshatriya, PP, Schwartz, J, Schwarzbauer, J, Karuri, NW. A surface derivatization strategy for combinatorial analysis of cell response to mixtures of protein domains. Langmuir. 2012;28:548-556.
41. Balklava Z, Verderio E, Collighan R, Gross S, Adams J, Griffin M. Analysis of tissue transglutaminase function in the migration of swiss 3T3 fibroblasts - The active-state conformation of the enzyme does not affect cell motility but is important for its secretion. J Biol Chem. 2002;277:16567-16575.
42. Dalton SL, Scharf E, Briesewitz R, Marcantonio EE, Assoian RK. Cell-adhesion to extracellular-matrix regulates the life-cycle of integrins. Mol Biol Cell. 1995;6:1781-1791.
43. Hanks SK, Calalb MB, Harper MC, Patel SK. Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin. Proc Natl Acad Sci USA. 1992;89:8487-8491.
44. Son HJ, Han DW, Kim HH, Kim HJ, Lee IS, Kim JK, Park JC. Attachment and proliferation of human dermal fibroblasts onto ECM-immobilized PLGA films. In: Zhang X, Tanaka J, Yu Y, Tabata Y. editors. ASBM6: Advanced Biomaterials VI. Zurich-Uetikon: Trans Tech Publications Ltd; 2005:288-289, 291-294.
45. Wang RX, Clark RAF, Mosher DF, Ren XD. Fibronectin's central cell-binding domain supports focal adhesion formation and rho signal transduction. J Biol Chem. 2005;280:28803-28810.
46. Seppa HE, Yamada KM, Seppa ST, Silver MH, Kleinman HK, Schiffmann E., The cell binding fragment of fibronectin is chemotactic for fibroblasts. Cell Biol Int Rep. 1981;5:813-819.
47. Postlethwaite AE, Keski-Oja J, Balian G, Kang AH., Induction of fibroblast chemotaxis by fibronectin. Localization of the chemotactic region to a 140, 000-molecular weight non-gelatin-binding fragment. J Exp Med. 1981;153:494-499.
48. Alfandari D, Cousin H, Gaultier A, Hoffstrom BG, DeSimone DW. Integrin alpha5beta1 supports the migration of Xenopus cranial neural crest on fibronectin. Dev Biol. 2003;260:449-464.
49. Karuri NW, Lin Z, Rye HS, Schwarzbauer JE. Probing the conformation of the fibronectin III1-2 domain by fluorescence resonance energy transfer. J Biol Chem. 2009;284:3445-3452.
50. Burton-Wurster N, Gendelman R, Chen H, Gu DN, Tetreault JW, Lust G, Schwarzbauer JE, MacLeod JN. The cartilage-specific (V+C)- fibronectin isoform exists primarily in homodimeric and monomeric configurations. Biochem J. 1999;341 (Pt 3):555-561.
51. Schwarzbauer JE. Alternative splicing of fibronectin: three variants, three functions. Bioessays. 1991;13:527-533.
52. Tamkun JW, Schwarzbauer JE, Hynes RO. A single rat fibronectin gene generates three different mRNAs by alternative splicing of a complex exon. Proc Natl Acad Sci USA. 1984;81:5140-5144.
53. Ohashi T, Kiehart DP, Erickson HP. Dynamics and elasticity of the fibronectin matrix in living cell culture visualized by fibronectin-green fluorescent protein. Proc Natl Acad Sci USA. 1999;96:2153-2158.
54. Smith ML, Gourdon D, Little WC, Kubow KE, Eguiluz RA, Luna-Morris S, Vogel V. Force-induced unfolding of fibronectin in the extracellular matrix of living cells. PLoS Biol. 2007;5:e268.
55. Valenick LV, Hsia HC, Schwarzbauer JE. Fibronectin fragmentation promotes alpha4beta1 integrin-mediated contraction of a fibrin-fibronectin provisional matrix. Exp Cell Res. 2005;309:48-55.
56. Schwarzbauer JE, Spencer CS, Wilson CL. Selective secretion of alternatively spliced fibronectin variants. J Cell Biol. 1989;109:3445-3453.
57. Manabe R, Ohe N, Maeda T, Fukuda T, Sekiguchi K. Modulation of cell-adhesive activity of fibronectin by the alternatively spliced EDA segment. J Cell Biol. 1997;139:295-307.
58. Bernard BA, Yamada KM, Olden K. Carbohydrates selectively protect a specific domain of fibronectin against proteases. J Biol Chem. 1982;257:8549-8554.
59. Hahn LH, Yamada KM. Identification and isolation of a collagen-binding fragment of the adhesive glycoprotein fibronectin. Proc Natl Acad Sci USA. 1979;76:1160-1163.
60. Clark RA. Basics of cutaneous wound repair. J Dermatol Surg Oncol. 1993;19:693-706.
61. Stroncek JD, Bell N, Reichert WM. Instructional PowerPoint presentations for cutaneous wound healing and tissue response to sutures. J Biomed Mater Res A. 2009;90:1230-1238.
62. Grace MJ, Lee S, Bradshaw S, Chapman J, Spond J, Cox S, Delorenzo M, Brassard D, Wylie D, Cannon-Carlson S, Cullen C, Indelicato S, Voloch M, Bordens R. Site of pegylation and polyethylene glycol molecule size attenuate interferon-alpha antiviral and antiproliferative activities through the JAK/STAT signaling pathway. J Biol Chem. 2005;280:6327-6336.
63. Roberts MJ, Bentley MD, Harris JM. Chemistry for peptide and protein PEGylation. Adv Drug Delivery Rev. 2002;54:459-476.